EP Patent

EP1772145A1 — Method of effectively using medicine and method concerning prevention of side effect

Assigned to Kyorin Pharmaceutical Co Ltd · Expires 2007-04-11 · 19y expired

What this patent protects

To provide a medicament which efficiently expresses an immunosuppressive agent or an anti-inflammatory agent and reduces expression of side effect. A medicament includes diaryl sulfide or diaryl ether compound having a 2-amino-1,3-propanediol structure having an activity of…

USPTO Abstract

To provide a medicament which efficiently expresses an immunosuppressive agent or an anti-inflammatory agent and reduces expression of side effect. A medicament includes diaryl sulfide or diaryl ether compound having a 2-amino-1,3-propanediol structure having an activity of reducing lymphocytes circulating peripherally, in combination with an immunosuppressive agent and/or an anti-inflammatory agent.

Drugs covered by this patent

Patent Metadata

Patent number
EP1772145A1
Jurisdiction
EP
Classification
—
Expires
2007-04-11
Drug substance claim
No
Drug product claim
No
Assignee
Kyorin Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.